VOLUME 68   2007   NUMBER 2

Editorial

185 The Art (and Blood Sport) of Psychopharmacology Research: Who Has a Dog in the Fight? Alan J. Gelenberg and Marlene P. Freeman
[PDF]

Original Articles

186 Longitudinal Effects of Personality Disorders on Psychosocial Functioning of Patients With Major Depressive Disorder. John C. Markowitz, Andrew E. Skodol, Eva Petkova, Jianfeng Cheng, Charles A. Sanislow, Carlos M. Grilo, John G. Gunderson, and Thomas H. McGlashan
[Abstract] [PDF]

194 Persisting Low Use of Antipsychotics in the Treatment of Major Depressive Disorder With Psychotic Features. Carmen Andreescu, Benoit H. Mulsant, Catherine Peasley-Miklus, Anthony J. Rothschild, Alastair J. Flint, Moonseong Heo, Melynda Caswell, Ellen M. Whyte, and Barnett S. Meyers, for the STOP-PD Study Group
[Abstract] [PDF]

201 Efficacy and Safety of Topiramate Monotherapy in Civilian Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Study. Phebe Tucker, Richard P. Trautman, Dorothy B. Wyatt, Jamie Thompson, Shu-Chen Wu, Julie A. Capece, and Norman R. Rosenthal
[Abstract] [PDF]

207 Health-Related Quality of Life in Euthymic Bipolar Disorder Patients: Differences Between Bipolar I and II Subtypes. [CME] Giuseppe Maina, Umberto Albert, Laura Bellodi, Cristina Colombo, Carlo Faravelli, Palmiero Monteleone, Filippo Bogetto, Giovanni B. Cassano, and Mario Maj
[Abstract] [PDF]

213 Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine. John M. Kane, Herbert Y. Meltzer, William H. Carson, Jr., Robert D. McQuade, Ronald N. Marcus, and Raymond Sanchez, for the Aripiprazole Study Group
[Abstract] [PDF]

224 A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine,
and Fluoxetine in Treatment-Resistant Major Depressive Disorder. Michael E. Thase, Sara A. Corya, Olawale Osuntokun, Michael Case, David B. Henley, Todd M. Sanger, Susan B. Watson, and Sanjay Dubé
[Abstract] [PDF]

237 Melatonin in Schizophrenic Outpatients With Insomnia: A Double-Blind, Placebo-Controlled Study. P. N. Suresh Kumar, Chittaranjan Andrade, Savita G. Bhakta, and Nagendra M. Singh
[Abstract] [PDF]

242 Predictors of Suicide in First-Episode Affective and Nonaffective Psychotic Inpatients: Five-Year Follow-Up of Patients From a Catchment Area in Vitoria, Spain. Ana González-Pinto, Ana Aldama, Cristina González, Fernando Mosquera, Marta Arrasate, and Eduard Vieta
[Abstract] [PDF]

248 Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care. Paul A. Fishman, Paul E. Stang, and Susan L. Hogue
[Abstract] [PDF]

254 A Comparison of Rates of Residual Insomnia Symptoms Following Pharmacotherapy or Cognitive-Behavioral Therapy for Major Depressive Disorder. Colleen E. Carney, Zindel V. Segal, Jack D. Edinger, and Andrew D. Krystal
[Abstract] [PDF]

261 Effect of Bupropion Extended Release on Negative Emotion Processing in Major Depressive Disorder: A Pilot Functional Magnetic Resonance Imaging Study. Brigitte Robertson, Lihong Wang, Michele T. Diaz, Marilyn Aiello, Kenneth Gersing, John Beyer, Srinivasan Mukundan, Jr., Gregory McCarthy, and P. Murali Doraiswamy
[Abstract] [PDF]

268 Efficacy of a Novel Biphasic Controlled-Release Methylphenidate Formula in Adults With
Attention-Deficit/Hyperactivity Disorder: Results of a Double-Blind, Placebo-Controlled Crossover Study. Umesh Jain, Lily Hechtman, Margaret Weiss, Tahira S. Ahmed, Joseph L. Reiz, Graeme A. E. Donnelly, Zoltan Harsanyi, and Andrew C. Darke
[Abstract] [PDF]

278 Are Day Hospitals Effective for Acutely Ill Psychiatric Patients? A European Multicenter Randomized Controlled Trial. Thomas W. Kallert, Stefan Priebe, Rosemarie McCabe, Andrzej Kiejna, Joanna Rymaszewska, Petr Nawka, Ladislav Oăvár, Jií Raboch, Lucie Stárková-Kaliová, Rainer Koch, and Matthias Schützwohl
[Abstract] [PDF]

288 Nefazodone in the Treatment of Generalized Social Phobia: A Randomized, Placebo-Controlled Trial. Michael Van Ameringen, Catherine Mancini, Jonathan Oakman, John Walker, Kevin Kjernisted, Pratap Chokka, David Johnston, Mark Bennett, and Beth Patterson
[Abstract] [PDF]

Focus on Childhood and Adolescent Mental Health

296 Can Research Inform the Clinical Care of Mental Health Disorders in Children and Adolescents? Melissa P. DelBello
[PDF]

297 Adaptive Functioning and Psychiatric Symptoms in Adolescents With Borderline Personality Disorder. Andrew M. Chanen, Martina Jovev, and Henry J. Jackson
[Abstract] [PDF]

307 Diagnostic Characteristics of Child Bipolar I Disorder: Does the "Treatment of Early Age Mania (TEAM)" Sample Generalize? Rebecca Tillman and Barbara Geller
[Abstract] [PDF]

Academic Highlights

315 Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression. [CME]
[PDF]

ASCP Corner

331 The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment. Leslie Citrome
[PDF]

Letters To the Editor

333 A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia. Georges M. Gharabawi, Cynthia A. Bossie, Gahan J. Pandina, Mary J. Kujawa, Andrew J. Greenspan, and Young Zhu
[PDF]

  • Reply by Dennis E. Sweitzer, Arthur Lazarus, and Martin Brecher

334 Indexing of Reports on Aripiprazole Augmentation of Clozapine. Adam Keller Ashton
[PDF]

  • Reply by Harpreet S. Duggal and Dattatreya N. Mendhekar

335 Successful Use of Phenelzine in Treatment-Resistant Panic Disorder. Sandip Buch and Michael Wagner
[PDF]

336 Azithromycin and Catatonic Symptoms. Niraj Ahuja
[PDF]

  • Reply by Maria Teresa Plana and Jordi Blanch

337 Delayed Sleep Phase Syndrome, ADHD, and Bright Light Therapy. Reut Gruber, Natalie Grizenko, and Ridha Joober
[PDF]

338 Correction. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, and Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry (J Clin Psychiatry 2006;67:1954-1967)
[PDF]

Book Reviews 339

Electronic CME Activities

Available through www.psychiatrist.com/toc

e03 A History of the Concept of Atypical Depression. Jonathan R. T. Davidson and Michael E. Thase

e04 Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials. Jeffrey A. Lieberman

e05 Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia. Robert A. Rosenheck and Jeffrey A. Lieberman